Stoke Therapeutics, Inc. (STOK)
32.93
-1.03
(-3.03%)
USD |
NASDAQ |
Mar 17, 15:44
Stoke Therapeutics Profit Margin (Quarterly) : -360.7% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | -2.24% |
| Krystal Biotech, Inc. | 47.99% |
| Scholar Rock Holding Corp. | -- |
| Vertex Pharmaceuticals, Inc. | 36.91% |
| Zymeworks, Inc. | -1.64K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.95% |
| Return on Assets | 11.82% |
| Return on Invested Capital | 13.73% |
| Gross Profit Margin (Quarterly) | 90.70% |
| Operating Margin (Quarterly) | -405.3% |
| Return on Net Operating Assets | 197.6% |